NEW YORK, Jan 4 (Reuters) - A U.S. federal judge has denied motions to certify classes of users of osteoporosis drug Fosamax who wanted Merck & Co to set up a program to monitor them for an ailment ...

Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 2008;168:826-831. Data from the Group Health Atrial ...

Please provide your email address to receive an email when new articles are posted on . Denosumab as a first-line osteoporosis therapy is linked to lower fracture risks than alendronate among ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Alendronate, a drug commonly used to ...

Fosamax is a brand name of the generic drug alendronate. This type of medication helps treat osteoporosis due to menopause or steroid use. It alters bone formation and the breakdown of the bones in ...

Compared with alendronate, teriparatide was associated with significantly greater pain reduction and better quality of life among postmenopausal women with osteoporosis. Teriparatide has a favorable ...